Amedica Corporation Provides Update on its Clinical Studies SALT LAKE CITY, May 08, 2018 (GLOBE NEWSWIRE) -- Amedica Corporation (NASDAQ: AMDA), an innovative biomaterial company that develops and commercializes silicon nitride for biomedical applications,...

Amedica Granted Extension by NASDAQ to Regain Compliance with NASDAQ Listing Rule SALT LAKE CITY, March 15, 2018 (GLOBE NEWSWIRE) -- Amedica Corporation (Nasdaq:AMDA), an innovative biomaterial company which develops and manufactures silicon nitride as a platform for biomedical...

Amedica Announces Reverse Stock Split SALT LAKE CITY, Nov. 10, 2017 (GLOBE NEWSWIRE) -- Amedica Corporation (Nasdaq:AMDA), an innovative biomaterial company that develops and manufactures silicon nitride as a platform for biomedical...

Amedica Receives Positive Nasdaq Listing Decision SALT LAKE CITY, Oct. 17, 2017 (GLOBE NEWSWIRE) -- Amedica Corporation (Nasdaq: AMDA) (the “Company”), an innovative biomaterial company that develops and manufactures silicon nitride as a platform...